1. Preliminary data of VEGF-A and VEGFR-2 polymorphisms as predictive factors of radiological response and clinical outcome in iodine-refractory differentiated thyroid cancer treated with sorafenib
   Vincenzo Marotta et al, 2017, Endocrine CrossRef
2. Association of VEGF haplotypes with breast cancer risk in North-West Indians
   Vasudha Sambyal et al, 2021, BMC Medical Genomics CrossRef
3. Vascular endothelial growth factor (VEGF) gene polymorphisms and breast cancer risk in Punjabi population from North West India
   Ruhi Kapahi et al, 2014, Tumor Biology CrossRef
4. Association of ABCB1 and VEGFA gene polymorphisms with breast cancer susceptibility and prognosis
   Adela Madrid-Paredes et al, 2020, Pathology - Research and Practice CrossRef
5. Vascular endothelial growth factor polymorphisms affect gene expression and tumor aggressiveness in patients with breast cancer
   DOONYAPAT SA-NGUANRAKSA et al, 2014, Molecular Medicine Reports CrossRef
6. Prognostic evaluation of VEGFA genotypes and haplotypes in a cohort of Brazilian women with non metastatic breast cancer
   Hayra de Andrade Vieira-Monteiro et al, 2016, Cancer Biology & Therapy CrossRef
7. Association of vascular endothelial growth factor polymorphisms with clinical outcome of renal cell carcinoma patients
   Weifeng Zhong et al, 2014, Tumor Biology CrossRef
8. Survival outcome of combined GnRH agonist and tamoxifen is comparable to that of sequential adriamycin and cyclophosphamide chemotherapy plus tamoxifen in premenopausal patients with early breast cancer
   Doonyapat Sa‑Nguanraksa et al, 2019, Molecular and Clinical Oncology CrossRef
9. Association of Genetic Variants in ANGPT/TEK and VEGF/VEGFR with Progression and Survival in Head and Neck Squamous Cell Carcinoma Treated with Radiotherapy or Radiochemotherapy
   Dorota Butkiewicz et al, 2020, Cancers CrossRef
10. Clinicopathologic Features of Breast Carcinomas Classified by Biomarkers and Correlation with Microvessel Density and VEGF Expression: A Study from Thailand
    Tuenjai Chuangsuwanich et al, 2014, Asian Pacific Journal of Cancer Prevention CrossRef
11. Association between VEGF single nucleotide polymorphism and breast cancer in the Northern China Han population
    Ziyao Li et al, 2021, Breast Cancer Research and Treatment CrossRef
12. Role of five small nucleotide polymorphisms in the VEGF gene on the susceptibility to osteosarcoma and overall survival of patients
    JIAN-QIANG LIU et al, 2015, Oncology Letters CrossRef
13. Vascular endothelial growth factor A (VEGFA) promoter rs2010963 polymorphism and cancer risk: An updated meta-analysis and trial sequential analysis
    Md. Abdul Aziz et al, 2022, Meta Gene CrossRef
14. Predictive value of vascular endothelial growth factor polymorphisms on the risk of renal cell carcinomas: a case–control study
    Guangjian Lu et al, 2015, Tumor Biology CrossRef
15. Association of vascular endothelial growth factor – A gene polymorphisms and haplotypes with breast cancer metastases
    Uwe Langsenlehner et al, 2015, Acta Oncologica CrossRef
16. Prognostic and predictive role of vascular endothelial growth factor polymorphisms in breast cancer
    Angelos Koutras et al, 2015, Pharmacogenomics CrossRef
17. Predictive value of vascular endothelial growth factor polymorphisms on the clinical outcome of renal cell carcinoma patients
    NAN MA et al, 2015, Oncology Letters CrossRef
18. The Association BetweenVEGF+936C/T and −634G/C Polymorphisms and Breast Cancer Susceptibility, Tumor Growth, and Metastases: Evidence From 20,728 Subjects
    Jianguo Ma et al, 2015, Cancer Investigation CrossRef
19. Investigation of Vascular Endothelial Growth Factor Polymorphisms on Risk, Metastasis, Laterality, and Prognosis of Colorectal Cancer in Turkish Subjects
    Mehtap Cevik et al, 2022, Genetic Testing and Molecular Biomarkers CrossRef